Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF394 - Provider product page
- Provider
- R&D Systems
- Product name
- Human CCL18/PARC Biotinylated Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects human CCL18/PARC in ELISAs and Western blots. In sandwich ELISAs, less than 0.1% cross-reactivity with recombinant human (rh) HCC-1, rhMPIF-1, rhMIP-1 alpha , recombinant mouse (rm) MIP-1 alpha , rhMIP-1 beta , rmMIP-1 beta , recombinant viral (rv) MIP-I, rvMIP-II, and rhMIP-1 delta is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Biotin
- Antigen sequence
P55774- Isotype
- IgG
- Vial size
- 50 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists.
Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis.
Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.
Potential biomarkers of osteonecrosis in Gaucher disease.
Ossorio M, Martínez V, Bajo MA, Del Peso G, Castro MJ, Romero S, Selgas R, Bellón T
BioMed research international 2018;2018:6415892
BioMed research international 2018;2018:6415892
Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis.
Quillinan N, Clark KE, Youl B, Vernes J, McIntosh D, Haq S, Denton CP
Arthritis research & therapy 2017 Mar 7;19(1):45
Arthritis research & therapy 2017 Mar 7;19(1):45
Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.
Deegan PB, Pavlova E, Tindall J, Stein PE, Bearcroft P, Mehta A, Hughes D, Wraith JE, Cox TM
Medicine 2011 Jan;90(1):52-60
Medicine 2011 Jan;90(1):52-60
Potential biomarkers of osteonecrosis in Gaucher disease.
Pavlova EV, Deegan PB, Tindall J, McFarlane I, Mehta A, Hughes D, Wraith JE, Cox TM
Blood cells, molecules & diseases 2011 Jan 15;46(1):27-33
Blood cells, molecules & diseases 2011 Jan 15;46(1):27-33
No comments: Submit comment
No validations: Submit validation data